01/11/2023 Argaam Exclusive
AI Summary
Shares of Nahdi Medical Co. fell to their lowest level today, Nov. 1, at SAR 132.
| Year High (SAR) | Year Low (SAR) |
| 204.80 | 132.00 |
| Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
| 209.40 | 132.00 |
The stock closed at a record low today at SAR 134.40 (-5%), with nearly 1.5 million shares traded.
Accordingly, year-to-date losses reached 20%. The stock fell 23% in the last three months.
The company’s Q3 2023 net earnings dropped 16% year-on-year to SAR 212.8 million.
| Open | 112.80 |
| Low | 111.10 |
| High | 112.80 |
| Previous Close | 111.30 |
| Change (3M) | (11.75 %) |
| Change (6M) | (4.68 %) |
| Market Value | 14,547.00 |
| Avg. Volume (3M) | 145,910.36 |
| Avg. Turnover (3M) | 17,933,868.52 |
| Avg. Transaction (3M) | 2,237.50 |
| Change(12M) | (14.58 %) |
| YTD | (4.85 %) |
The company’s capital has not been changed since its debut in 2022.
| Date | Type | Capital (M Riyal) | Change (%) |
| 2022 | IPO | 1,300.00 | 0.00% |
| Financial Ratio | Current |
| Market Cap (M Riyal) | 14,547.01 |
| Shares Outstanding ((M)) | 130.00 |
| EPS ( ) (TTM) | 6.41 |
| Book Value (BV) ( Riyal) (Latest announcement) | 20.68 |
| Recurring P/E | 18.58 |
| Price/book | 5.41 |
| Dividend Yield (%) (Last Year) | 4.92 |
| Return on Average Assets (%) (TTM) | 13.73 |
| Return on Average Equity (%) (TTM) | 31.66 |
| Par Value ( Riyal) | 10.00 |
| Enterprise Value (EV) (M Riyal) | 13,855.14 |
| EV/adj EBITDA | 8.57 |
| EV/Revenues | 1.40 |
Fair Average Price
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Neutral | Citi Bank Group | 157.00 | 180.00 | 14.65 % |
Be the first to comment
Comments Analysis: